{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:31:13Z","timestamp":1773923473280,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00417-025-07088-x","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:13:10Z","timestamp":1767492790000},"page":"945-954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation between intracystic reflectivity and intraocular inflammation in diabetic macular edema: a novel inflammatory biomarker"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-4970","authenticated-orcid":false,"given":"Tahsin","family":"Uzundede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ak\u0131n","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eren","family":"Vurgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan B.","family":"Velio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilan","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezin D.","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa N.","family":"El\u00e7io\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"7088_CR1","doi-asserted-by":"crossref","unstructured":"Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A et al (2016) Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory. J Diabetes Res 2016","DOI":"10.1155\/2016\/2156273"},{"key":"7088_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.4103\/ijo.IJO_1240_18","volume":"66","author":"DJ Browning","year":"2018","unstructured":"Browning DJ, Stewart MW, Lee C (2018) Diabetic macular edema: evidence-based management. Indian J Ophthalmol 66:1736\u20131750","journal-title":"Indian J Ophthalmol"},{"key":"7088_CR3","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","volume":"121","author":"MC Gillies","year":"2014","unstructured":"Gillies MC, Lim LL, Campain A et al (2014) A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 121:2473\u20132481. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.002","journal-title":"Ophthalmology"},{"key":"7088_CR4","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1097\/IAE.0000000000000533","volume":"35","author":"RK Maturi","year":"2015","unstructured":"Maturi RK, Bleau L, Saunders J et al (2015) A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-VEGF injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy. Retina 35:1604\u20131614","journal-title":"Retina"},{"key":"7088_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00417-016-3472-1","volume":"255","author":"DG Callanan","year":"2017","unstructured":"Callanan DG, Loewenstein A, Patel SS et al (2017) A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 255:463\u2013473. https:\/\/doi.org\/10.1007\/s00417-016-3472-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7088_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","volume":"399","author":"CC Wykoff","year":"2022","unstructured":"Wykoff CC, Abreu F, Adamis AP et al (2022) Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet 399:741\u2013755. https:\/\/doi.org\/10.1016\/S0140-6736(22)00018-6","journal-title":"Lancet"},{"key":"7088_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(23)02577-1","volume":"403","author":"DM Brown","year":"2024","unstructured":"Brown DM, Boyer DS, Do DV et al (2024) Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2\/3 trial. Lancet 403:1153\u20131163. https:\/\/doi.org\/10.1016\/S0140-6736(23)02577-1","journal-title":"Lancet"},{"key":"7088_CR8","doi-asserted-by":"publisher","unstructured":"(2015) Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema. N Engl J Med 372:1193\u20131203. https:\/\/doi.org\/10.1056\/NEJMoa1414264","DOI":"10.1056\/NEJMoa1414264"},{"key":"7088_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5552824","author":"M Li","year":"2021","unstructured":"Li M, Li J, Chen K et al (2021) Association between inflammatory factors in the aqueous humor and hyperreflective foci in patients with intractable macular edema treated with antivascular endothelial growth factor. Dis Markers. https:\/\/doi.org\/10.1155\/2021\/5552824","journal-title":"Dis Markers"},{"key":"7088_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9402198","author":"H Wu","year":"2017","unstructured":"Wu H, Hwang DK, Song X, Tao Y (2017) Association between aqueous cytokines and diabetic retinopathy stage. J Ophthalmol. https:\/\/doi.org\/10.1155\/2017\/9402198","journal-title":"J Ophthalmol"},{"key":"7088_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920\u2013927. https:\/\/doi.org\/10.1016\/S0161-6420(02)00975-2","journal-title":"Ophthalmology"},{"key":"7088_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2147\/OPTH.S79948","volume":"9","author":"PU Dugel","year":"2015","unstructured":"Dugel PU, Bandello F, Loewenstein A (2015) Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol 9:1321\u20131335","journal-title":"Clin Ophthalmol"},{"key":"7088_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1080\/14656566.2017.1363182","volume":"18","author":"D Veritti","year":"2017","unstructured":"Veritti D, Sarao V, Diplotti L et al (2017) Fluocinolone acetonide for the treatment of diabetic macular edema. Expert Opin Pharmacother 18:1507\u20131516. https:\/\/doi.org\/10.1080\/14656566.2017.1363182","journal-title":"Expert Opin Pharmacother"},{"key":"7088_CR14","doi-asserted-by":"publisher","unstructured":"Karatas E (2024) Pearl necklace sign and other optical coherence tomography findings in retinal vein occlusion at the first visit. Eur Eye Res 1\u20136. https:\/\/doi.org\/10.14744\/eer.2023.50570","DOI":"10.14744\/eer.2023.50570"},{"key":"7088_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10792-018-0874-6","volume":"39","author":"F Yenihayat","year":"2019","unstructured":"Yenihayat F, \u00d6zkan B, Kasap M et al (2019) Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid. Int Ophthalmol 39:821\u2013828. https:\/\/doi.org\/10.1007\/s10792-018-0874-6","journal-title":"Int Ophthalmol"},{"key":"7088_CR16","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00417-021-05083-6","volume":"259","author":"R Venkatesh","year":"2021","unstructured":"Venkatesh R, Sangai S, Reddy NG et al (2021) Intracystic hyperreflective material in centre-involving diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 259:2533\u20132544. https:\/\/doi.org\/10.1007\/s00417-021-05083-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7088_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/ICB.0b013e31828eef49","volume":"7","author":"MC Liang","year":"2013","unstructured":"Liang MC, Vora RA, Duker JS, Reichel E (2013) Solid-appearing retinal cysts in diabetic macular edema: a novel optical coherence tomography finding. Retin Cases Brief Rep 7:255\u2013258","journal-title":"Retin Cases Brief Rep"},{"key":"7088_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/IAE.0000000000000282","volume":"35","author":"T Horii","year":"2015","unstructured":"Horii T, Murakami T, Akagi T, OPTICAL Coherence tomographic reflectivity of cystoid spaces is related to recurrent diabetic macular edema after triamcinolone (2015) Retina 35:264\u2013271. https:\/\/doi.org\/10.1097\/IAE.0000000000000282","journal-title":"Retina"},{"key":"7088_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.oret.2017.11.004","volume":"2","author":"AH Kashani","year":"2018","unstructured":"Kashani AH, Green KM, Kwon J et al (2018) Suspended scattering particles in motion: a novel feature of OCT angiography in exudative maculopathies. Ophthalmol Retina 2:694\u2013702. https:\/\/doi.org\/10.1016\/j.oret.2017.11.004","journal-title":"Ophthalmol Retina"},{"key":"7088_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11892-013-0382-z","volume":"13","author":"LA Owen","year":"2013","unstructured":"Owen LA, Hartnett ME (2013) Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. Curr Diab Rep 13:476\u2013480. https:\/\/doi.org\/10.1007\/s11892-013-0382-z","journal-title":"Curr Diab Rep"},{"key":"7088_CR21","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","volume":"110","author":"H Funatsu","year":"2003","unstructured":"Funatsu H, Yamashita H, Ikeda T et al (2003) Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110:1690\u20131696. https:\/\/doi.org\/10.1016\/S0161-6420(03)00568-2","journal-title":"Ophthalmology"},{"key":"7088_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ophtha.2008.09.036","volume":"116","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH et al (2009) Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 116:80\u201386. https:\/\/doi.org\/10.1016\/j.ophtha.2008.09.036","journal-title":"Ophthalmology"},{"key":"7088_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203408","author":"Jwoo Kwon","year":"2018","unstructured":"Kwon Jwoo, Jee D (2018) Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0203408","journal-title":"PLoS One"},{"key":"7088_CR24","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1097\/IAE.0b013e3182576d07","volume":"32","author":"JB Jonas","year":"2012","unstructured":"Jonas JB, Jonas RA, Neumaier M, Findeisen P (2012) Cytokine concentration in aqueous humor of eyes with diabetic macular edema. RetinA 32:2150\u20132157","journal-title":"RETINA"},{"key":"7088_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/IAE.0b013e31821801de","volume":"32","author":"H Noma","year":"2012","unstructured":"Noma H, Funatsu H, Mimura T et al (2012) Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusioN. Retina 32:86\u201391. https:\/\/doi.org\/10.1097\/IAE.0b013e31821801de","journal-title":"Retina"},{"key":"7088_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1124\/jpet.119.262956","volume":"373","author":"S Torres-Costa","year":"2020","unstructured":"Torres-Costa S, Alves Valente MC, Falc\u00e3o-Reis F, Falc\u00e3o M (2020) Cytokines and growth factors as predictors of response to medical treatment in diabetic macular edema. J Pharmacol Exp Ther 373:445\u2013452. https:\/\/doi.org\/10.1124\/jpet.119.262956","journal-title":"J Pharmacol Exp Ther"},{"key":"7088_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/09273948.2014.949779","volume":"24","author":"S Mitrovi\u0107","year":"2016","unstructured":"Mitrovi\u0107 S, Kelava T, \u0160u\u0107ur A, Gr\u010devi\u0107 D (2016) Levels of selected aqueous humor mediators (IL-10, IL-17, CCL2, VEGF, FasL) in diabetic cataract. Ocul Immunol Inflamm 24:159\u2013166. https:\/\/doi.org\/10.3109\/09273948.2014.949779","journal-title":"Ocul Immunol Inflamm"},{"key":"7088_CR28","doi-asserted-by":"publisher","first-page":"1106706","DOI":"10.3389\/fendo.2023.1106706","volume":"14","author":"LKY Chan","year":"2023","unstructured":"Chan LKY, Lin SS, Chan F, Ng DS-C (2023) Optimizing treatment for diabetic macular edema during cataract surgery. Front Endocrinol (Lausanne) 14:1106706. https:\/\/doi.org\/10.3389\/fendo.2023.1106706","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7088_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","volume":"99","author":"D Bellocq","year":"2015","unstructured":"Bellocq D, Korobelnik JF, Burillon C et al (2015) Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol 99:979\u2013983. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306159","journal-title":"Br J Ophthalmol"},{"key":"7088_CR30","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00417-023-06138-6","volume":"261","author":"AM Khattab","year":"2023","unstructured":"Khattab AM, Hagras SM, Lotfy NM (2023) Pre-operative versus post-operative intravitreal aflibercept injection for management of DME in patients undergoing cataract surgery. Graefes Arch Clin Exp Ophthalmol 261:3223\u20133229. https:\/\/doi.org\/10.1007\/s00417-023-06138-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07088-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07088-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:37:18Z","timestamp":1773909438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07088-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7088"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07088-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki and ethical approval was obtained from the Institutional Ethical Board of Prof Dr Cemil Ta\u015fc\u0131o\u011flu City Hospital in Istanbul, Turkey (Approval ID: E-48670771-514.99.237217819).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None of the authors has any conflicts of interest or competing interests regarding the materials used in the research and has any financial disclosure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}